Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Lite Strategy Inc (LITS)

Lite Strategy Inc (LITS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Lite Strategy Inc 9920 Pacific Heights Blvd. Suite 150 SAN DIEGO CA 92121 USA

https://litestrategy.com Employees: 4 P: 858-369-7100

Sector:

Medical

Description:

MEI Pharma, Inc. is an oncology company focused on the clinical development of novel therapeutics targeting cancer metabolism. The Company is focused on the clinical development of its two lead isoflavone-based drug candidates, ME-143 and ME-344. MEI Pharma, Inc., formerly known as Marshall Edwards, Inc., is based in San Diego.

Key Statistics

Overview:

Market Capitalization, $K 41,182
Enterprise Value, $K 23,172
Shares Outstanding, K 36,770
Float, K 36,182
% Float 98.40%
Short Interest, K 114
Short Float 0.31%
Days to Cover 1.00
Short Volume Ratio 0.24
% of Insider Shareholders 1.60%
% of Institutional Shareholders 52.38%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -15,950 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -3,640 K
EBIT, $ -12,840 K
EBITDA, $ -12,470 K

Growth:

1-Year Return -58.82%
3-Year Return -82.50%
5-Year Return -98.66%
5-Year Revenue Growth -100.00%
5-Year Earnings Growth 54.04%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.12 on 11/14/25
Next Earnings Date 02/11/26
Earnings Per Share ttm -0.99
EPS Growth vs. Prev Year 90.00%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-20 on 04/17/23

LITS Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -26.58%
Return-on-Assets % -24.93%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow 0.17
Price/Book 0.33
Book Value/Share 3.15
Interest Coverage -0.18
60-Month Beta 0.32
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar